Teacher Retirement System of Texas Cuts Holdings in Globe Life Inc. $GL

Key Points

• Teacher Retirement System of Texas trimmed its stake in Globe Life by 24.1% in Q4, selling 7,991 shares and leaving it with 25,159 shares worth about $3.52 million.
• Globe Life reported quarterly EPS of $3.43 (missing estimates by $0.03) with revenue of $1.56 billion in line with expectations, and set FY2026 guidance at 15.40–15.90 EPS (analysts expect ~15.45).
• The company raised its quarterly dividend to $0.33 from $0.27 (annualized $1.32, ~0.9% yield), while insiders sold 116,807 shares (~$17.3M) over the past 90 days; institutional ownership stands near 81.6% and the consensus analyst rating is Buy with a $172.67 target.

Teacher Retirement System of Texas trimmed its position in Globe Life Inc. (NYSE:GL - Free Report) by 24.1% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 25,159 shares of the company's stock after selling 7,991 shares during the period. Teacher Retirement System of Texas' holdings in Globe Life were worth $3,519,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. AQR Capital Management LLC boosted its stake in shares of Globe Life by 98.6% in the 2nd quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company's stock worth $174,340,000 after buying an additional 696,548 shares during the last quarter. Balyasny Asset Management L.P. bought a new stake in Globe Life during the third quarter worth $80,925,000. Westfield Capital Management Co. LP bought a new stake in Globe Life during the third quarter worth $61,569,000. Comerica Bank boosted its position in Globe Life by 865.4% in the third quarter. Comerica Bank now owns 152,662 shares of the company's stock worth $21,826,000 after purchasing an additional 136,849 shares during the last quarter. Finally, Qube Research & Technologies Ltd boosted its position in Globe Life by 368.7% in the third quarter. Qube Research & Technologies Ltd now owns 137,461 shares of the company's stock worth $19,653,000 after purchasing an additional 108,135 shares during the last quarter. Hedge funds and other institutional investors own 81.61% of the company's stock.

Globe Life Stock Performance

Globe Life stock opened at $152.17 on Tuesday. Globe Life Inc. has a 1-year low of $111.13 and a 1-year high of $155.08. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.39. The firm has a market capitalization of $11.94 billion, a PE ratio of 10.52 and a beta of 0.47. The firm's 50 day simple moving average is $143.82 and its 200 day simple moving average is $139.68.

Globe Life (NYSE:GL - Get Free Report) last announced its quarterly earnings results on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing the consensus estimate of $3.46 by ($0.03). The firm had revenue of $1.56 billion during the quarter, compared to the consensus estimate of $1.56 billion. Globe Life had a net margin of 19.38% and a return on equity of 21.30%. The firm's revenue for the quarter was up 5.3% on a year-over-year basis. During the same period in the previous year, the business earned $3.07 earnings per share. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. As a group, analysts expect that Globe Life Inc. will post 15.45 earnings per share for the current fiscal year.

Globe Life Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Friday, April 3rd will be paid a dividend of $0.33 per share. This is a positive change from Globe Life's previous quarterly dividend of $0.27. This represents a $1.32 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Thursday, April 2nd. Globe Life's dividend payout ratio is 9.13%.

Insider Buying and Selling at Globe Life

In other Globe Life news, EVP Michael Clay Majors sold 34,000 shares of the company's stock in a transaction dated Friday, April 24th. The stock was sold at an average price of $153.81, for a total value of $5,229,540.00. Following the transaction, the executive vice president directly owned 53,518 shares in the company, valued at $8,231,603.58. This represents a 38.85% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Frank M. Svoboda sold 12,500 shares of the firm's stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $144.78, for a total value of $1,809,750.00. Following the completion of the sale, the chief executive officer directly owned 35,868 shares in the company, valued at approximately $5,192,969.04. The trade was a 25.84% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 116,807 shares of company stock valued at $17,270,826 over the last 90 days. Insiders own 2.11% of the company's stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on GL. Texas Capital raised Globe Life to a "strong-buy" rating in a research report on Wednesday, March 18th. Wells Fargo & Company boosted their price target on shares of Globe Life from $171.00 to $172.00 and gave the stock an "overweight" rating in a report on Friday, April 10th. JPMorgan Chase & Co. increased their price target on shares of Globe Life from $180.00 to $181.00 and gave the company an "overweight" rating in a research report on Thursday, February 5th. Truist Financial raised their price objective on shares of Globe Life from $180.00 to $185.00 and gave the stock a "buy" rating in a report on Friday. Finally, Weiss Ratings raised shares of Globe Life from a "hold (c+)" rating to a "buy (b)" rating in a research report on Monday, April 13th. Two analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus target price of $172.67.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.

Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.